Immune-mediated epilepsies in children

by E. D. Belousova, M. I. Yablonskaya, M. K. Tagirova, S. L. Kulikova, S. A. Likhachev
Published 2016-03-01

The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues

by A. M. Lila, E. A. Galushko, A. V. Gordeev, A. S. Semashko
Published 2021-02-01

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease

by T. A. Lisitsyna, Z. S. Alekberova, G. A. Davydova, T. M. Reshetnyak, L. A. Katargina, E. L. Nasonov
Published 2020-09-01

2019 Coronavirus disease (COVID-19): contribution of rheumatology

by Evgeny L. Nasonov
Published 2021-05-01

INTERACTION BETWEEN SYMPATHO-ADRENAL ACTIVITY AND IMMUNE MEDIATORS IN PATIENTS WITH METABOLIC SYNDROME

by N. R. Uzbekova, M. A. Khuzhamberdiev, I. M. Tashtemirova
Published 2014-03-01

The role of the procalcitonin test in the diagnosis of infections in immune-mediated inflammatory rheumatic diseases

by N. V. Muravyeva, B. S. Belov, G. M. Tarasova
Published 2019-12-01

Immune-mediated adverse rheumatic reactions following administration of immune checkpoint inhibitors

by I. V. Menshikova, V. V. Strogonova
Published 2020-09-01

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)

by E. L. Nasonov, A. S. Avdeeva, A. M. Lila
Published 2020-02-01

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review

by Marina A. Lyadova, Vladimir K. Lyadov
Published 2021-08-01

Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy

by M. I. Kaleda, I. P. Nikishina, E. V. Nikolaeva, A. N. Shapovalenko, E. S. Fedorov, T. N. Pachkoria
Published 2021-05-01

Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract

by G. B. Dikke, A. A. Sukhanov, I. I. Kukarskaya, V. V. Ostromenskii
Published 2021-07-01

Influence of the Epstein-Barr Virus Persistence upon the Development of the ImmuneMediated Somatic Diseases

by S. A. Yakushina, L. B. Kisteneva
Published 2018-03-01

EFFICACY AND SAFETY OF TOFACITINIB FOR IMMUNEMEDIATED INFLAMMATORY RHEUMATIC DISEASES (PART II)

by E. L. Nasonov, A. S. Avdeeva, A. M. Lila
Published 2020-04-01

Early prescription of biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An expert’s opinion

by D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, A. V. Veselov, T. V. Korotaeva, A. M. Lila, E. Yu. Loginova, E. V. Sokolovskiy, M. M. Khobeish, M. V. Shapina, O. B. Shchukina
Published 2020-09-01

BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES

by E. L. Nasonov, A. M. Lila
Published 2020-06-01

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

by E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev
Published 2020-09-01

Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia

by E. L. Nasonov, A. M. Lila, V. I. Mazurov, B. S. Belov, A. E. Karateev, T. V. Dubinina, O. A. Nikitinskaya, A. A. Baranov, D. I. Abdulganieva, S. V. Moiseev, A. I. Zagrebneva
Published 2021-07-01

The development of rheumatology at the stage of formation of a new technological paradigm

by T. V. Beketova
Published 2019-11-01

Biologic agents in immune-mediated inflammatory rheumatic diseases: current state of the art and clinical practice in Romania

by A. Balanesc, D. DinuBala, D. DinuBala
Published 2017-09-01

Coronavirus disease 2019 (COVID-19) and autoimmunity

by E. L. Nasonov
Published 2021-03-01